Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Vessel Anomalies | 11 | 2022 | 314 | 3.210 |
Why?
|
Physical Endurance | 8 | 2013 | 387 | 2.250 |
Why?
|
Vascular Diseases | 11 | 2022 | 1154 | 2.220 |
Why?
|
Cardiology | 9 | 2022 | 1638 | 1.660 |
Why?
|
Takotsubo Cardiomyopathy | 3 | 2021 | 117 | 1.550 |
Why?
|
Running | 8 | 2009 | 466 | 1.190 |
Why?
|
Physicians, Women | 4 | 2019 | 471 | 1.120 |
Why?
|
Athletes | 8 | 2019 | 1038 | 1.110 |
Why?
|
Heart Ventricles | 10 | 2020 | 3851 | 1.100 |
Why?
|
Sports | 5 | 2013 | 652 | 1.090 |
Why?
|
Physical Fitness | 4 | 2010 | 706 | 1.000 |
Why?
|
Adaptation, Physiological | 7 | 2019 | 1333 | 0.960 |
Why?
|
Coronary Angiography | 9 | 2022 | 4383 | 0.900 |
Why?
|
Ventricular Function, Right | 6 | 2019 | 580 | 0.880 |
Why?
|
Ventricular Function, Left | 9 | 2022 | 3411 | 0.870 |
Why?
|
Exercise | 10 | 2016 | 5251 | 0.850 |
Why?
|
Pregnancy Complications, Cardiovascular | 3 | 2021 | 511 | 0.800 |
Why?
|
Heart Failure | 13 | 2022 | 10040 | 0.730 |
Why?
|
Echocardiography | 13 | 2021 | 5139 | 0.720 |
Why?
|
Echocardiography, Doppler | 4 | 2019 | 972 | 0.690 |
Why?
|
Ventricular Function | 3 | 2012 | 427 | 0.660 |
Why?
|
Physical Exertion | 4 | 2012 | 711 | 0.640 |
Why?
|
Ventricular Remodeling | 5 | 2020 | 1280 | 0.630 |
Why?
|
Myocardial Ischemia | 4 | 2022 | 2114 | 0.600 |
Why?
|
Death, Sudden, Cardiac | 3 | 2017 | 1493 | 0.580 |
Why?
|
Coronary Artery Disease | 5 | 2020 | 6213 | 0.560 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2019 | 338 | 0.560 |
Why?
|
Heart Valve Diseases | 3 | 2021 | 1053 | 0.540 |
Why?
|
Anesthetics | 1 | 2020 | 525 | 0.540 |
Why?
|
Shock, Cardiogenic | 1 | 2019 | 591 | 0.530 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2009 | 2042 | 0.510 |
Why?
|
Aneurysm, Dissecting | 2 | 2021 | 647 | 0.490 |
Why?
|
Sex Factors | 12 | 2022 | 10566 | 0.490 |
Why?
|
Aortic Valve Stenosis | 2 | 2019 | 1832 | 0.480 |
Why?
|
Troponin T | 5 | 2009 | 753 | 0.480 |
Why?
|
Stroke Volume | 8 | 2022 | 4522 | 0.440 |
Why?
|
Cardiovascular Diseases | 10 | 2022 | 14075 | 0.420 |
Why?
|
Electrocardiography | 8 | 2017 | 6386 | 0.410 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2006 | 578 | 0.410 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2011 | 255 | 0.400 |
Why?
|
Heart-Assist Devices | 2 | 2019 | 1238 | 0.400 |
Why?
|
Natriuretic Peptide, Brain | 7 | 2022 | 1574 | 0.400 |
Why?
|
Chest Pain | 1 | 2017 | 1100 | 0.390 |
Why?
|
Exercise Tolerance | 3 | 2012 | 802 | 0.390 |
Why?
|
Salaries and Fringe Benefits | 3 | 2022 | 269 | 0.390 |
Why?
|
Ultrasonography, Doppler | 1 | 2012 | 466 | 0.380 |
Why?
|
Menopause, Premature | 2 | 2021 | 126 | 0.370 |
Why?
|
Sports Medicine | 1 | 2012 | 236 | 0.370 |
Why?
|
Mitral Valve Insufficiency | 1 | 2019 | 1355 | 0.360 |
Why?
|
Iliac Vein | 1 | 2009 | 73 | 0.360 |
Why?
|
Aorta | 2 | 2016 | 2120 | 0.350 |
Why?
|
Competitive Behavior | 1 | 2009 | 85 | 0.350 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2018 | 952 | 0.350 |
Why?
|
Myocardial Contraction | 2 | 2012 | 1659 | 0.350 |
Why?
|
Community Health Services | 2 | 2013 | 661 | 0.340 |
Why?
|
Defibrillators, Implantable | 1 | 2017 | 1377 | 0.340 |
Why?
|
Skating | 1 | 2007 | 20 | 0.330 |
Why?
|
Dobutamine | 1 | 2007 | 124 | 0.320 |
Why?
|
Humans | 93 | 2022 | 708843 | 0.320 |
Why?
|
Preventive Health Services | 1 | 2012 | 583 | 0.320 |
Why?
|
Iliac Artery | 1 | 2009 | 384 | 0.320 |
Why?
|
Female | 68 | 2022 | 375205 | 0.310 |
Why?
|
Lymphoma, AIDS-Related | 1 | 2007 | 83 | 0.310 |
Why?
|
Echocardiography, Stress | 1 | 2007 | 131 | 0.310 |
Why?
|
Heart | 2 | 2011 | 4315 | 0.300 |
Why?
|
Arteriovenous Fistula | 1 | 2009 | 300 | 0.290 |
Why?
|
Patient Care Team | 2 | 2021 | 2587 | 0.290 |
Why?
|
Male | 57 | 2022 | 349524 | 0.280 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2011 | 867 | 0.280 |
Why?
|
Primary Prevention | 1 | 2013 | 1134 | 0.280 |
Why?
|
Heart Diseases | 2 | 2016 | 2759 | 0.280 |
Why?
|
Burkitt Lymphoma | 1 | 2007 | 362 | 0.270 |
Why?
|
American Heart Association | 2 | 2020 | 973 | 0.260 |
Why?
|
Peripartum Period | 2 | 2022 | 111 | 0.260 |
Why?
|
Gadolinium | 1 | 2009 | 910 | 0.250 |
Why?
|
Career Choice | 2 | 2022 | 743 | 0.250 |
Why?
|
Wounds, Gunshot | 1 | 2009 | 537 | 0.240 |
Why?
|
Heart Neoplasms | 1 | 2007 | 385 | 0.240 |
Why?
|
Internship and Residency | 1 | 2022 | 5556 | 0.230 |
Why?
|
Women's Health | 3 | 2022 | 1898 | 0.230 |
Why?
|
Menopause | 2 | 2020 | 1518 | 0.230 |
Why?
|
Tai Ji | 3 | 2012 | 267 | 0.230 |
Why?
|
Hemodynamics | 2 | 2011 | 4211 | 0.220 |
Why?
|
Peptide Fragments | 4 | 2009 | 5141 | 0.220 |
Why?
|
Cardiomyopathies | 2 | 2022 | 1819 | 0.210 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3495 | 0.210 |
Why?
|
Fibromuscular Dysplasia | 1 | 2021 | 68 | 0.210 |
Why?
|
Mass Screening | 4 | 2012 | 5182 | 0.210 |
Why?
|
Adult | 27 | 2022 | 211041 | 0.200 |
Why?
|
Middle Aged | 33 | 2022 | 213752 | 0.200 |
Why?
|
Echocardiography, Doppler, Color | 4 | 2012 | 389 | 0.190 |
Why?
|
Students | 1 | 2010 | 1562 | 0.190 |
Why?
|
Diastole | 3 | 2019 | 836 | 0.190 |
Why?
|
Oxidative Stress | 1 | 2011 | 3156 | 0.190 |
Why?
|
Altitude Sickness | 2 | 2011 | 80 | 0.190 |
Why?
|
Tramadol | 1 | 2019 | 47 | 0.190 |
Why?
|
Treatment Outcome | 9 | 2020 | 61932 | 0.190 |
Why?
|
Sex Distribution | 3 | 2019 | 2328 | 0.180 |
Why?
|
Risk Factors | 17 | 2022 | 69553 | 0.180 |
Why?
|
Coronary Vessels | 2 | 2020 | 2964 | 0.170 |
Why?
|
Complementary Therapies | 1 | 2003 | 517 | 0.170 |
Why?
|
Postnatal Care | 1 | 2020 | 225 | 0.170 |
Why?
|
Systole | 3 | 2011 | 993 | 0.170 |
Why?
|
Dissection | 1 | 2019 | 281 | 0.170 |
Why?
|
Myocardium | 3 | 2011 | 4969 | 0.170 |
Why?
|
Women's Health Services | 1 | 2018 | 93 | 0.170 |
Why?
|
Authorship | 1 | 2021 | 266 | 0.170 |
Why?
|
Bibliometrics | 1 | 2021 | 334 | 0.160 |
Why?
|
Risk Adjustment | 1 | 2021 | 587 | 0.160 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 688 | 0.150 |
Why?
|
Athletic Injuries | 1 | 2006 | 1132 | 0.150 |
Why?
|
Myocardial Infarction | 4 | 2021 | 11323 | 0.150 |
Why?
|
Infertility | 1 | 2022 | 565 | 0.150 |
Why?
|
Ultrasonography | 5 | 2013 | 5918 | 0.140 |
Why?
|
Cardiac Output | 2 | 2009 | 904 | 0.140 |
Why?
|
Risk Assessment | 8 | 2018 | 23284 | 0.140 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 665 | 0.140 |
Why?
|
Registries | 4 | 2020 | 7989 | 0.140 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2020 | 415 | 0.140 |
Why?
|
Hospitals, General | 2 | 2018 | 712 | 0.140 |
Why?
|
Medical History Taking | 2 | 2010 | 804 | 0.140 |
Why?
|
Internal Medicine | 1 | 2022 | 1007 | 0.140 |
Why?
|
Patient Care Management | 1 | 2019 | 319 | 0.140 |
Why?
|
Dilatation, Pathologic | 1 | 2016 | 517 | 0.140 |
Why?
|
Kidney Failure, Chronic | 1 | 2007 | 2559 | 0.130 |
Why?
|
Pregnancy | 9 | 2022 | 26832 | 0.130 |
Why?
|
Boston | 4 | 2019 | 9402 | 0.130 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15252 | 0.130 |
Why?
|
Estrogen Replacement Therapy | 1 | 2000 | 1178 | 0.120 |
Why?
|
Young Adult | 12 | 2020 | 55940 | 0.120 |
Why?
|
Aged | 19 | 2022 | 161488 | 0.120 |
Why?
|
Delivery, Obstetric | 1 | 2020 | 894 | 0.120 |
Why?
|
Medicare | 3 | 2021 | 5691 | 0.120 |
Why?
|
Echocardiography, Transesophageal | 3 | 2007 | 1109 | 0.110 |
Why?
|
United States | 11 | 2022 | 67165 | 0.110 |
Why?
|
Osteoarthritis | 1 | 2019 | 960 | 0.110 |
Why?
|
Prospective Studies | 8 | 2022 | 50597 | 0.110 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 883 | 0.110 |
Why?
|
Hypertension, Pulmonary | 2 | 2021 | 1489 | 0.110 |
Why?
|
Societies, Medical | 2 | 2017 | 3776 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1108 | 0.110 |
Why?
|
Hypertension | 2 | 2021 | 8161 | 0.110 |
Why?
|
Echocardiography, Doppler, Pulsed | 2 | 2010 | 78 | 0.110 |
Why?
|
Education, Medical, Continuing | 1 | 2017 | 868 | 0.110 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2013 | 203 | 0.110 |
Why?
|
Heart Rate | 4 | 2019 | 4094 | 0.100 |
Why?
|
Sensitivity and Specificity | 4 | 2011 | 14836 | 0.100 |
Why?
|
Oxygen Consumption | 4 | 2012 | 1928 | 0.100 |
Why?
|
Analysis of Variance | 3 | 2011 | 6530 | 0.100 |
Why?
|
False Positive Reactions | 2 | 2011 | 1004 | 0.100 |
Why?
|
Self Efficacy | 2 | 2012 | 629 | 0.100 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2022 | 2290 | 0.100 |
Why?
|
Mountaineering | 1 | 2010 | 44 | 0.100 |
Why?
|
Reference Values | 5 | 2011 | 5041 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2021 | 1403 | 0.090 |
Why?
|
Health Status Disparities | 2 | 2018 | 1711 | 0.090 |
Why?
|
Iliac Aneurysm | 1 | 2009 | 40 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2244 | 0.090 |
Why?
|
Leadership | 1 | 2018 | 1325 | 0.090 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2011 | 775 | 0.090 |
Why?
|
Endothelin-1 | 1 | 2011 | 317 | 0.090 |
Why?
|
Bundle-Branch Block | 1 | 2011 | 276 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4317 | 0.090 |
Why?
|
Faculty, Medical | 1 | 2017 | 1156 | 0.090 |
Why?
|
Fee-for-Service Plans | 1 | 2013 | 650 | 0.080 |
Why?
|
Blood Pressure | 4 | 2011 | 8528 | 0.080 |
Why?
|
Collateral Circulation | 1 | 2009 | 311 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2011 | 723 | 0.080 |
Why?
|
Longitudinal Studies | 5 | 2022 | 13536 | 0.080 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2020 | 935 | 0.080 |
Why?
|
Blood | 1 | 2010 | 624 | 0.080 |
Why?
|
Vulnerable Populations | 1 | 2013 | 650 | 0.080 |
Why?
|
Heredity | 2 | 2018 | 169 | 0.080 |
Why?
|
Cardiac Volume | 1 | 2007 | 214 | 0.080 |
Why?
|
Physical Education and Training | 1 | 2007 | 108 | 0.080 |
Why?
|
Massachusetts | 2 | 2017 | 8712 | 0.080 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 3316 | 0.080 |
Why?
|
Myoglobin | 1 | 2006 | 158 | 0.080 |
Why?
|
Prevalence | 3 | 2019 | 14712 | 0.080 |
Why?
|
Ships | 1 | 2006 | 63 | 0.080 |
Why?
|
Troponin | 1 | 2010 | 505 | 0.080 |
Why?
|
Myocardial Stunning | 1 | 2006 | 72 | 0.080 |
Why?
|
Aortic Valve | 1 | 2016 | 1817 | 0.080 |
Why?
|
Life Style | 3 | 2018 | 3636 | 0.080 |
Why?
|
Body Constitution | 1 | 2006 | 275 | 0.070 |
Why?
|
Comorbidity | 4 | 2020 | 10339 | 0.070 |
Why?
|
Creatine Kinase, MB Form | 1 | 2006 | 221 | 0.070 |
Why?
|
Blood Chemical Analysis | 1 | 2008 | 460 | 0.070 |
Why?
|
Shock | 1 | 2008 | 321 | 0.070 |
Why?
|
Health Status Indicators | 1 | 2011 | 987 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2018 | 2996 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2011 | 2920 | 0.070 |
Why?
|
Recurrence | 1 | 2017 | 8255 | 0.070 |
Why?
|
Coronary Circulation | 2 | 2009 | 1652 | 0.070 |
Why?
|
Fibroma | 1 | 2007 | 215 | 0.070 |
Why?
|
Pericardial Effusion | 1 | 2007 | 233 | 0.070 |
Why?
|
Prognosis | 6 | 2022 | 28919 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2022 | 71483 | 0.070 |
Why?
|
Genetic Testing | 1 | 2018 | 3303 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3562 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2011 | 2402 | 0.070 |
Why?
|
Brain Infarction | 1 | 2007 | 302 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1551 | 0.070 |
Why?
|
Elasticity Imaging Techniques | 1 | 2009 | 366 | 0.070 |
Why?
|
Mitral Valve Stenosis | 1 | 2007 | 382 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 2 | 2009 | 34151 | 0.070 |
Why?
|
Pulmonary Artery | 2 | 2011 | 1899 | 0.060 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2004 | 62 | 0.060 |
Why?
|
Incidence | 4 | 2020 | 20320 | 0.060 |
Why?
|
Cardiotonic Agents | 1 | 2007 | 550 | 0.060 |
Why?
|
Time Factors | 5 | 2019 | 41038 | 0.060 |
Why?
|
Physical Examination | 1 | 2010 | 1245 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3308 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 13274 | 0.060 |
Why?
|
Peroxidase | 1 | 2006 | 636 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 1104 | 0.060 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2011 | 1565 | 0.060 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2004 | 157 | 0.060 |
Why?
|
Sex Characteristics | 1 | 2013 | 2510 | 0.060 |
Why?
|
Causality | 1 | 2009 | 1137 | 0.060 |
Why?
|
Fibrillar Collagens | 1 | 2022 | 40 | 0.060 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 23020 | 0.060 |
Why?
|
Platelet Activation | 1 | 2006 | 658 | 0.060 |
Why?
|
Blood Flow Velocity | 1 | 2006 | 1468 | 0.060 |
Why?
|
Probability | 1 | 2007 | 2474 | 0.050 |
Why?
|
Creatinine | 1 | 2007 | 1885 | 0.050 |
Why?
|
Parental Leave | 1 | 2022 | 80 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4615 | 0.050 |
Why?
|
Prostheses and Implants | 1 | 2009 | 1341 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2315 | 0.050 |
Why?
|
Poverty | 1 | 2013 | 2557 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 2144 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2022 | 21194 | 0.050 |
Why?
|
Minority Health | 1 | 2021 | 85 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2019 | 58184 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 15485 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6765 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2016 | 20308 | 0.050 |
Why?
|
Rural Health | 1 | 2021 | 292 | 0.050 |
Why?
|
Codeine | 1 | 2019 | 44 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3690 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8896 | 0.050 |
Why?
|
Socioeconomic Factors | 3 | 2022 | 7644 | 0.050 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2009 | 1312 | 0.050 |
Why?
|
Diclofenac | 1 | 2019 | 67 | 0.050 |
Why?
|
Observer Variation | 1 | 2006 | 2687 | 0.050 |
Why?
|
Naproxen | 1 | 2019 | 99 | 0.050 |
Why?
|
Norway | 1 | 2020 | 456 | 0.050 |
Why?
|
Perioperative Care | 1 | 2007 | 1067 | 0.040 |
Why?
|
Age Factors | 2 | 2018 | 18712 | 0.040 |
Why?
|
Exercise Test | 1 | 2006 | 2125 | 0.040 |
Why?
|
Calcinosis | 1 | 2007 | 1435 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2010 | 2968 | 0.040 |
Why?
|
Aneurysm | 1 | 2021 | 335 | 0.040 |
Why?
|
Dyspnea | 1 | 2006 | 1237 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2022 | 825 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2011 | 16008 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1028 | 0.040 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2004 | 859 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2012 | 7487 | 0.040 |
Why?
|
Parity | 1 | 2020 | 888 | 0.040 |
Why?
|
Body Weight | 1 | 2008 | 4680 | 0.040 |
Why?
|
Amyloidosis | 1 | 2004 | 788 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2011 | 19423 | 0.040 |
Why?
|
Incidental Findings | 1 | 2021 | 668 | 0.040 |
Why?
|
Cardiovascular Agents | 2 | 2018 | 863 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 636 | 0.040 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2004 | 1195 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2009 | 3984 | 0.040 |
Why?
|
Quality of Life | 3 | 2012 | 11594 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 266 | 0.030 |
Why?
|
Angiography | 1 | 2021 | 1675 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2317 | 0.030 |
Why?
|
Educational Status | 1 | 2022 | 2278 | 0.030 |
Why?
|
Walking | 2 | 2012 | 1096 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4969 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7763 | 0.030 |
Why?
|
Cohort Studies | 3 | 2021 | 39292 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2000 | 767 | 0.030 |
Why?
|
Affect | 2 | 2012 | 1487 | 0.030 |
Why?
|
Patient Preference | 1 | 2021 | 856 | 0.030 |
Why?
|
Uganda | 1 | 2017 | 1097 | 0.030 |
Why?
|
Estrogens | 1 | 2000 | 1511 | 0.030 |
Why?
|
Amygdala | 1 | 2021 | 1278 | 0.030 |
Why?
|
Mutation | 1 | 2018 | 29262 | 0.030 |
Why?
|
Heart Atria | 2 | 2011 | 1286 | 0.030 |
Why?
|
Health Services Research | 1 | 2021 | 1836 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 17218 | 0.030 |
Why?
|
Forearm | 1 | 1995 | 406 | 0.030 |
Why?
|
Propensity Score | 1 | 2019 | 1715 | 0.030 |
Why?
|
Job Satisfaction | 1 | 2017 | 555 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2021 | 1988 | 0.030 |
Why?
|
Stroke | 2 | 2021 | 9256 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2876 | 0.030 |
Why?
|
Atrial Function, Right | 1 | 2011 | 36 | 0.030 |
Why?
|
Torsion, Mechanical | 1 | 2010 | 20 | 0.030 |
Why?
|
Genetic Markers | 1 | 2018 | 2690 | 0.030 |
Why?
|
Equipment Design | 2 | 2012 | 3627 | 0.030 |
Why?
|
Particulate Matter | 1 | 2022 | 2288 | 0.030 |
Why?
|
Health Resources | 1 | 2017 | 922 | 0.030 |
Why?
|
Equipment Safety | 1 | 2012 | 274 | 0.030 |
Why?
|
Premenopause | 1 | 1995 | 1009 | 0.030 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 2010 | 24 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2003 | 3025 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2007 | 6170 | 0.020 |
Why?
|
Learning Curve | 1 | 2012 | 202 | 0.020 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2010 | 73 | 0.020 |
Why?
|
Environment, Controlled | 1 | 2010 | 48 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4724 | 0.020 |
Why?
|
Heart Septum | 1 | 2011 | 322 | 0.020 |
Why?
|
Education, Medical | 1 | 2021 | 1683 | 0.020 |
Why?
|
Lipids | 1 | 2000 | 3246 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 2713 | 0.020 |
Why?
|
Resistance Training | 1 | 2010 | 150 | 0.020 |
Why?
|
Pulmonary Gas Exchange | 1 | 2010 | 376 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2709 | 0.020 |
Why?
|
Curriculum | 1 | 2021 | 3329 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2376 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9641 | 0.020 |
Why?
|
Cardiomegaly | 1 | 2011 | 653 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1588 | 0.020 |
Why?
|
Acidosis, Lactic | 1 | 2008 | 128 | 0.020 |
Why?
|
Animals | 3 | 2022 | 170486 | 0.020 |
Why?
|
Microbubbles | 1 | 2007 | 118 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2010 | 731 | 0.020 |
Why?
|
Medicaid | 1 | 2019 | 2613 | 0.020 |
Why?
|
Emergency Service, Hospital | 2 | 2022 | 7428 | 0.020 |
Why?
|
Heart Valves | 1 | 2007 | 293 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6666 | 0.020 |
Why?
|
Developing Countries | 1 | 2017 | 2674 | 0.020 |
Why?
|
Hyponatremia | 1 | 2008 | 302 | 0.020 |
Why?
|
Cell Degranulation | 1 | 2006 | 298 | 0.020 |
Why?
|
Equipment Failure | 1 | 2007 | 586 | 0.020 |
Why?
|
Magnesium | 1 | 2008 | 852 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12292 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 1758 | 0.020 |
Why?
|
Europe | 1 | 2011 | 3104 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2000 | 8024 | 0.020 |
Why?
|
Outpatients | 1 | 2011 | 1349 | 0.020 |
Why?
|
Lactic Acid | 1 | 2008 | 1126 | 0.010 |
Why?
|
ROC Curve | 1 | 2011 | 3518 | 0.010 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2006 | 696 | 0.010 |
Why?
|
Sodium | 1 | 2008 | 1637 | 0.010 |
Why?
|
Device Removal | 1 | 2007 | 656 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 4883 | 0.010 |
Why?
|
Norepinephrine | 1 | 2004 | 912 | 0.010 |
Why?
|
Bone Density | 1 | 1995 | 3395 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2006 | 1670 | 0.010 |
Why?
|
Metabolomics | 1 | 2010 | 1357 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1938 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 11738 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 7089 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 24433 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16306 | 0.010 |
Why?
|
Mice | 2 | 2022 | 80876 | 0.010 |
Why?
|
Patient Compliance | 1 | 2011 | 2758 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2007 | 1481 | 0.010 |
Why?
|
Physicians | 1 | 2017 | 4292 | 0.010 |
Why?
|
Oxygen | 1 | 2011 | 4150 | 0.010 |
Why?
|
Adolescent | 3 | 2011 | 84718 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12447 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13468 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 16657 | 0.010 |
Why?
|
Blood Platelets | 1 | 2006 | 2485 | 0.010 |
Why?
|
Calcium | 1 | 2008 | 5825 | 0.010 |
Why?
|
Climate | 1 | 1995 | 123 | 0.010 |
Why?
|
Reproductive History | 1 | 1995 | 201 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2007 | 4297 | 0.010 |
Why?
|
Chronic Disease | 1 | 2004 | 8992 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 1995 | 1692 | 0.010 |
Why?
|
Body Composition | 1 | 1995 | 2393 | 0.000 |
Why?
|